Gene expression signatures of primary and metastatic uterine leiomyosarcoma

Ben Davidson, Vera Maria Abeler, Mette Førsund, Arild Holth, Yanqin Yang, Yusuke Kobayashi, Lily Chen, Gunnar B. Kristensen, Ie Ming Shih, Tian Li Wang

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Leiomyosarcoma (LMS) is the most common uterine sarcoma. Although the disease is relatively rare, it is responsible for considerable mortality due to frequent metastasis and chemoresistance. The molecular events related to LMS metastasis are unknown to date. The present study compared the global gene expression patterns of primary uterine LMSs and LMS metastases. Gene expression profiles of 13 primary and 15 metastatic uterine LMSs were analyzed using the HumanRef-8 BeadChip from Illumina. Differentially expressed candidate genes were validated using quantitative real-time polymerase chain reaction (PCR) and immunohistochemistry. To identify differently expressed genes between primary and metastatic tumors, we performed one-way analysis of variance with Benjamini-Hochberg correction. This led to identification of 203 unique probes that were significantly differentially expressed in the 2 tumor groups by greater than 1.58-fold with P <.01, of which 94 and 109 were overexpressed in primary and metastatic LMSs, respectively. Genes overexpressed in primary uterine LMSs included OSTN, NLGN4X, NLGN1, SLITRK4, MASP1, XRN2, ASS1, RORB, HRASLS, and TSPAN7. Genes overexpressed in LMS metastases included TNNT1, FOLR3, TDO2, CRYM, GJA1, TSPAN10, THBS1, SGK1, SHMT1, EGR2, and AGT. Quantitative real-time PCR confirmed significant anatomical site-related differences in FOLR3, OSTN, and NLGN4X levels; and immunohistochemistry showed significant differences in TDO2 expression. Gene expression profiling differentiates primary uterine LMSs from LMS metastases. The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.

Original languageEnglish
Pages (from-to)691-700
Number of pages10
JournalHuman Pathology
Volume45
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Leiomyosarcoma
Transcriptome
Neoplasm Metastasis
Genes
Real-Time Polymerase Chain Reaction
Neoplasms
Immunohistochemistry
Gene Expression Profiling
Sarcoma
Analysis of Variance
Gene Expression
Mortality

Keywords

  • Gene expression array
  • Metastasis
  • Uterine leiomyosarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Davidson, B., Abeler, V. M., Førsund, M., Holth, A., Yang, Y., Kobayashi, Y., ... Wang, T. L. (2014). Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Human Pathology, 45(4), 691-700. https://doi.org/10.1016/j.humpath.2013.11.003

Gene expression signatures of primary and metastatic uterine leiomyosarcoma. / Davidson, Ben; Abeler, Vera Maria; Førsund, Mette; Holth, Arild; Yang, Yanqin; Kobayashi, Yusuke; Chen, Lily; Kristensen, Gunnar B.; Shih, Ie Ming; Wang, Tian Li.

In: Human Pathology, Vol. 45, No. 4, 01.01.2014, p. 691-700.

Research output: Contribution to journalArticle

Davidson, B, Abeler, VM, Førsund, M, Holth, A, Yang, Y, Kobayashi, Y, Chen, L, Kristensen, GB, Shih, IM & Wang, TL 2014, 'Gene expression signatures of primary and metastatic uterine leiomyosarcoma', Human Pathology, vol. 45, no. 4, pp. 691-700. https://doi.org/10.1016/j.humpath.2013.11.003
Davidson, Ben ; Abeler, Vera Maria ; Førsund, Mette ; Holth, Arild ; Yang, Yanqin ; Kobayashi, Yusuke ; Chen, Lily ; Kristensen, Gunnar B. ; Shih, Ie Ming ; Wang, Tian Li. / Gene expression signatures of primary and metastatic uterine leiomyosarcoma. In: Human Pathology. 2014 ; Vol. 45, No. 4. pp. 691-700.
@article{6b93645d6d434c82b5fa23621f64bd0e,
title = "Gene expression signatures of primary and metastatic uterine leiomyosarcoma",
abstract = "Leiomyosarcoma (LMS) is the most common uterine sarcoma. Although the disease is relatively rare, it is responsible for considerable mortality due to frequent metastasis and chemoresistance. The molecular events related to LMS metastasis are unknown to date. The present study compared the global gene expression patterns of primary uterine LMSs and LMS metastases. Gene expression profiles of 13 primary and 15 metastatic uterine LMSs were analyzed using the HumanRef-8 BeadChip from Illumina. Differentially expressed candidate genes were validated using quantitative real-time polymerase chain reaction (PCR) and immunohistochemistry. To identify differently expressed genes between primary and metastatic tumors, we performed one-way analysis of variance with Benjamini-Hochberg correction. This led to identification of 203 unique probes that were significantly differentially expressed in the 2 tumor groups by greater than 1.58-fold with P <.01, of which 94 and 109 were overexpressed in primary and metastatic LMSs, respectively. Genes overexpressed in primary uterine LMSs included OSTN, NLGN4X, NLGN1, SLITRK4, MASP1, XRN2, ASS1, RORB, HRASLS, and TSPAN7. Genes overexpressed in LMS metastases included TNNT1, FOLR3, TDO2, CRYM, GJA1, TSPAN10, THBS1, SGK1, SHMT1, EGR2, and AGT. Quantitative real-time PCR confirmed significant anatomical site-related differences in FOLR3, OSTN, and NLGN4X levels; and immunohistochemistry showed significant differences in TDO2 expression. Gene expression profiling differentiates primary uterine LMSs from LMS metastases. The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.",
keywords = "Gene expression array, Metastasis, Uterine leiomyosarcoma",
author = "Ben Davidson and Abeler, {Vera Maria} and Mette F{\o}rsund and Arild Holth and Yanqin Yang and Yusuke Kobayashi and Lily Chen and Kristensen, {Gunnar B.} and Shih, {Ie Ming} and Wang, {Tian Li}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2013.11.003",
language = "English",
volume = "45",
pages = "691--700",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Gene expression signatures of primary and metastatic uterine leiomyosarcoma

AU - Davidson, Ben

AU - Abeler, Vera Maria

AU - Førsund, Mette

AU - Holth, Arild

AU - Yang, Yanqin

AU - Kobayashi, Yusuke

AU - Chen, Lily

AU - Kristensen, Gunnar B.

AU - Shih, Ie Ming

AU - Wang, Tian Li

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Leiomyosarcoma (LMS) is the most common uterine sarcoma. Although the disease is relatively rare, it is responsible for considerable mortality due to frequent metastasis and chemoresistance. The molecular events related to LMS metastasis are unknown to date. The present study compared the global gene expression patterns of primary uterine LMSs and LMS metastases. Gene expression profiles of 13 primary and 15 metastatic uterine LMSs were analyzed using the HumanRef-8 BeadChip from Illumina. Differentially expressed candidate genes were validated using quantitative real-time polymerase chain reaction (PCR) and immunohistochemistry. To identify differently expressed genes between primary and metastatic tumors, we performed one-way analysis of variance with Benjamini-Hochberg correction. This led to identification of 203 unique probes that were significantly differentially expressed in the 2 tumor groups by greater than 1.58-fold with P <.01, of which 94 and 109 were overexpressed in primary and metastatic LMSs, respectively. Genes overexpressed in primary uterine LMSs included OSTN, NLGN4X, NLGN1, SLITRK4, MASP1, XRN2, ASS1, RORB, HRASLS, and TSPAN7. Genes overexpressed in LMS metastases included TNNT1, FOLR3, TDO2, CRYM, GJA1, TSPAN10, THBS1, SGK1, SHMT1, EGR2, and AGT. Quantitative real-time PCR confirmed significant anatomical site-related differences in FOLR3, OSTN, and NLGN4X levels; and immunohistochemistry showed significant differences in TDO2 expression. Gene expression profiling differentiates primary uterine LMSs from LMS metastases. The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.

AB - Leiomyosarcoma (LMS) is the most common uterine sarcoma. Although the disease is relatively rare, it is responsible for considerable mortality due to frequent metastasis and chemoresistance. The molecular events related to LMS metastasis are unknown to date. The present study compared the global gene expression patterns of primary uterine LMSs and LMS metastases. Gene expression profiles of 13 primary and 15 metastatic uterine LMSs were analyzed using the HumanRef-8 BeadChip from Illumina. Differentially expressed candidate genes were validated using quantitative real-time polymerase chain reaction (PCR) and immunohistochemistry. To identify differently expressed genes between primary and metastatic tumors, we performed one-way analysis of variance with Benjamini-Hochberg correction. This led to identification of 203 unique probes that were significantly differentially expressed in the 2 tumor groups by greater than 1.58-fold with P <.01, of which 94 and 109 were overexpressed in primary and metastatic LMSs, respectively. Genes overexpressed in primary uterine LMSs included OSTN, NLGN4X, NLGN1, SLITRK4, MASP1, XRN2, ASS1, RORB, HRASLS, and TSPAN7. Genes overexpressed in LMS metastases included TNNT1, FOLR3, TDO2, CRYM, GJA1, TSPAN10, THBS1, SGK1, SHMT1, EGR2, and AGT. Quantitative real-time PCR confirmed significant anatomical site-related differences in FOLR3, OSTN, and NLGN4X levels; and immunohistochemistry showed significant differences in TDO2 expression. Gene expression profiling differentiates primary uterine LMSs from LMS metastases. The molecular signatures unique to primary and metastatic LMSs may aid in understanding tumor progression in this cancer and in providing a molecular basis for prognostic studies and therapeutic target discovery.

KW - Gene expression array

KW - Metastasis

KW - Uterine leiomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84896548189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896548189&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2013.11.003

DO - 10.1016/j.humpath.2013.11.003

M3 - Article

C2 - 24485798

AN - SCOPUS:84896548189

VL - 45

SP - 691

EP - 700

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 4

ER -